rs121434568, EGFR

N. diseases: 73
Disease: Non-small cell lung cancer recurrent ×
Source: ALL
Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Non-small cell lung cancer recurrent
CUI: C0278517
Disease: Non-small cell lung cancer recurrent
0.020 GeneticVariation BEFREE Eligible patients (≥20 years) with stage IIIB/IV or recurrent non-small-cell lung cancer and confirmed activating mutations of EGFR (exon 19 deletion or L858R point mutation in exon 21) received oral erlotinib 150 mg/day until disease progression or unacceptable toxicity. 27659294 2017
Non-small cell lung cancer recurrent
CUI: C0278517
Disease: Non-small cell lung cancer recurrent
0.020 GeneticVariation BEFREE Elderly patients aged 75 or older with advanced or recurrent NSCLC and EGFR mutations (exon 19 deletion or L858R mutation in exon 21) were enrolled in this prospective phase II trial. 26003540 2015